Dronabinol Capsules and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Dronabinol Capsules and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dronabinol
Brand name: Marinol, Syndros
Synonyms: Dronabinol
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dronabinol Capsules-Insulin glulisine
- Dronabinol Capsules-Insulin Glulisine (Cartridges and Pens)
- Dronabinol Capsules-Insulin Glulisine (Vials)
- Dronabinol Capsules-Insulin glulisine Subcutaneous
- Dronabinol Capsules-Insulin human inhaled Inhalation
- Dronabinol Capsules-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Dronabinol Oral Solution
- Insulin glargine, recombinant Subcutaneous-Dronedarone
- Insulin glargine, recombinant Subcutaneous-Dronedarone Hydrochloride
- Insulin glargine, recombinant Subcutaneous-Droperidol
- Insulin glargine, recombinant Subcutaneous-Droperidol Injection
- Insulin glargine, recombinant Subcutaneous-Drospirenone